You have 9 free searches left this month | for more free features.

Immune Therapy

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Trial in Rozzano (Rituximab)

Active, not recruiting
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
  • Rozzano, Milano, Italy
    Istituto Clinico Humanitas
May 17, 2023

Lung Cancer Stage IV Trial in Maastricht (Radiation)

Not yet recruiting
  • Lung Cancer Stage IV
  • Radiation
  • Maastricht, Netherlands
    Maastricht Radiation Oncology (Maastro)
Aug 29, 2023

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Valhalla (Gemtuzumab Ozogamicin)

Active, not recruiting
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Gemtuzumab Ozogamicin
  • Valhalla, New York
    New York Medical College
Sep 26, 2022

Intrahepatic Cholangiocarcinoma Trial (Transcatheter arterial chemoembolization, Multi-target Drug Therapy, Immunocheckpoint

Not yet recruiting
  • Intrahepatic Cholangiocarcinoma
  • Transcatheter arterial chemoembolization
  • +3 more
  • (no location specified)
Feb 17, 2022

Lung Cancer, NSCLC Trial in Tampa (Vorinostat, Pembrolizumab)

Active, not recruiting
  • Lung Cancer
  • Non-small Cell Lung Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 10, 2022

HIV Infection Trial in Italy, Netherlands, Spain (Analytical Treatment Interruption + bNAbs infusion)

Withdrawn
  • HIV Infection
  • Analytical Treatment Interruption + bNAbs infusion
  • Milan, Lombardy, Italy
  • +3 more
Aug 2, 2022

Recovery From Acute Immune Failure in Septic Shock by Immune

Recruiting
  • Severe Sepsis
    • Magdeburg, Germany
    • +1 more
    Nov 20, 2023

    Breast Cancer, Metastatic Cancer Trial (SHR-1316, SHR6390, Nab paclitaxel)

    Not yet recruiting
    • Breast Cancer
    • Metastatic Cancer
    • (no location specified)
    Jan 11, 2022

    Covid-19 Patients Trial in Giza (Cupping therapy with convential medical treatment, Convential medical treatment)

    Completed
    • Covid-19 Patients
    • Cupping therapy with convential medical treatment
    • Convential medical treatment
    • Giza, Egypt
      Faculty of physical therapy
    Jun 11, 2023

    Immune System Disorder Trial in Giza (Aerobic training, diet protocol)

    Recruiting
    • Immune System Disorder
    • Aerobic training
    • diet protocol
    • Giza, Egypt
      Faculty of Physical therapy, Cairo University
    Nov 20, 2023

    Immune Checkpoint Inhibitor Monotherapy or Combined With

    Not yet recruiting
    • Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeting Drugs / Locoregional Therapy for Hepatocellular Carcinoma
    • Immune checkpoint inhibitor
    • Guangzhou, Guangdong, China
      Department of Minimally Invasive and Interventional Radiology, L
    Jan 30, 2023

    Actinic Keratosis, Photodynamic Therapy Trial in Fairborn (Celecoxib 200mg, Placebo)

    Recruiting
    • Actinic Keratosis
    • Photodynamic Therapy
    • Celecoxib 200mg
    • Placebo
    • Fairborn, Ohio
      Wright State Physicians
    Jan 9, 2023

    Immune-related Adverse Events Refractory to Standard Therapy and

    Recruiting
    • Immune-related Adverse Event
    • Extracorporeal photopheresis
    • Other immunosuppressive or immunomodulatory drugs
    • Munich, Germany
      LMU Klinikum Hauttumorzentrum
    Jan 17, 2023

    Adjuvant Immune Checkpoint Inhibitors in Postoperative

    Recruiting
    • Hepatocellular Carcinoma
    • Immune Checkpoint Inhibitors Based Adjuvant therapy
    • Nanning, Guangxi, China
      Jian-Hong Zhong
    Jan 18, 2023

    Gastrointestinal Tumor Trial in Hangzhou (Water-filtered infrared A radiation whole-body hyperthermia (HECKEL 3000MT-4T,

    Completed
    • Gastrointestinal Tumor
    • Water-filtered infrared A radiation whole-body hyperthermia (HECKEL 3000MT-4T, Germany)
    • tislelizumab (BeiGene, China) combined with PD-1 inhibitor
    • Hangzhou, China
      Zhejiang Hospital
    Sep 1, 2023

    Immune-related Colitis, Colitis Trial in Minneapolis (RMT, Placebo)

    Not yet recruiting
    • Immune-related Colitis
    • Colitis
    • Minneapolis, Minnesota
      University of Minnesota
    Feb 4, 2023

    AIDS Virus, Disorder of Immune Reconstitution Trial in Jinan (normal saline, Mesenchymal stem cells)

    Recruiting
    • AIDS Virus
    • Disorder of Immune Reconstitution
    • normal saline
    • Mesenchymal stem cells
    • Jinan, Shandong, China
      Shandong Public Health Clinical Center
    May 14, 2023

    Immune Markers in Pediatric ITP

    Not yet recruiting
    • ITP - Immune Thrombocytopenia
    • complete blood count, CD3+ , CD4+ , CD8+, CD16+, CD56+, IFN-γ.
    • (no location specified)
    Oct 17, 2023

    Last Period Not Earlier Than 6 Months Ago Trial in Moscow (oral menopausal hormone therapy, transdermal menopausal hormone

    Active, not recruiting
    • Last Period Not Earlier Than 6 Months Ago
    • oral menopausal hormone therapy
    • transdermal menopausal hormone therapy
    • Moscow, Russian Federation
      Federal State Budget Institution Research Center for Obstetrics,
    Jan 9, 2023

    Pediatric Cancer Trial in Charlotte (Vaccine)

    Recruiting
    • Pediatric Cancer
    • Vaccine
    • Charlotte, North Carolina
      Levine Cancer Institute
    Jan 27, 2023

    Breast Cancer Trial in New York (Cryoablation, Ipilimumab, Nivolumab)

    Active, not recruiting
    • Breast Cancer
    • Cryoablation
    • +2 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jul 1, 2022

    Metastatic Pancreatic Cancer Trial in Rotterdam (Durvalumab, Rintatolimod)

    Not yet recruiting
    • Metastatic Pancreatic Cancer
    • Durvalumab
    • Rintatolimod
    • Rotterdam, Zuid-Holland, Netherlands
      Erasmus MC
    Jun 23, 2023

    Healthcare Resource Utilization and Costs of Immune Checkpoint

    Completed
    • Melanoma
      • East Hanover, New Jersey
        Novartis
      May 12, 2023

      Determine Pro-Inflammatory Cytokine Kinetics During Immune

      Not yet recruiting
      • Non Small Cell Lung Cancer
      • Melanoma
        • Indianapolis, Indiana
          Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
        Jan 30, 2023

        Sepsis, Severe Trial in Germany (ARTICE)

        Recruiting
        • Sepsis, Severe
        • ARTICE
        • Braunschweig, Germany
        • +3 more
        Jul 29, 2022